Trial set for Gilead HIV antitrust claims case

23-02-2023

Liz Hockley

Trial set for Gilead HIV antitrust claims case

Sundry Photography / Shutterstock.com

Gilead, Johnson & Johnson and others will face trial in May | Class-action suit involves allegations of anticompetitive practices.


Gilead Sciences, Johnson & Johnson, Japan Tobacco, HIV drugs, antitrust, cART

LSIPR